Key result
CKD in moderate-to-severe aortic stenosis is linked to ~96% higher mortality.
Why the study?
Management of aortic stenosis in patients with chronic kidney disease may often be overlooked, potentially conferring poorer outcomes.
Does concomitant chronic kidney disease increase mortality and heart failure admissions in patients with moderate to severe aortic stenosis?
Cohort (n=727)
No
Does concomitant chronic kidney disease increase mortality and heart failure admissions in patients with moderate to severe aortic stenosis?
Hazard Ratio: 1.96 (95% CI 1.5–2.57)
Absolute Event Rate: 50.4% vs 24.9%
p-value: p=<0.001
Concomitant CKD in patients with moderate to severe aortic stenosis is strongly associated with increased mortality and heart failure admissions, indicating a need for optimized care and monitoring in this high-risk population.
INTRODUCTION: Management of aortic stenosis (AS) in patients with chronic kidney disease (CKD) may often be overlooked, and this could confer poorer outcomes. METHODS: Consecutive patients ( n = 727) with index echocardiographic diagnosis of moderate to severe AS (aortic valve area <1.5 cm 2 ) were examined. They were divided into those with CKD (estimated glomerular filtration rate < 60 mL/min) and those without. Baseline clinical and echocardiographic parameters were compared, and a multivariate Cox regression model was constructed. Clinical outcomes were compared using Kaplan-Meier curves. RESULTS: There were 270 (37.1%) patients with concomitant CKD. The CKD group was older (78.0 ± 10.3 vs. 72.1 ± 12.9 years, P < 0.001), with a higher prevalence of hypertension, diabetes mellitus, hyperlipidaemia and ischaemic heart disease. AS severity did not differ significantly, but left ventricular (LV) mass index (119.4 ± 43.7 vs. 112.3 ± 40.6 g/m 2 , P = 0.027) and Doppler mitral inflow E to annular tissue Doppler e' ratio (E: e' 21.5 ± 14.6 vs. 17.8 ± 12.2, P = 0.001) were higher in the CKD group. There was higher mortality (log-rank 51.5, P < 0.001) and more frequent admissions for cardiac failure (log-rank 25.9, P < 0.001) in the CKD group, with a lower incidence of aortic valve replacement (log-rank 7.12, P = 0.008). On multivariate analyses, after adjusting for aortic valve area, age, left ventricular ejection fraction and clinical comorbidities, CKD remained independently associated with mortality (hazard ratio 1.96, 95% confidence interval 1.50-2.57, P < 0.001). CONCLUSION: Concomitant CKD in patients with moderate to severe AS was associated with increased mortality, more frequent admissions for cardiac failure and a lower incidence of aortic valve replacement.
No takes yet. Share an insight, caveat, or question.
Ngiam et al. (2023) conducted a cohort in Moderate to severe aortic stenosis (n=727). Chronic kidney disease (eGFR < 60 mL/min) vs. No chronic kidney disease (eGFR ≥ 60 mL/min) was evaluated on All-cause mortality (HR 1.96, 95% CI 1.50-2.57, p=<0.001). Concomitant chronic kidney disease in patients with moderate to severe aortic stenosis was independently associated with a 96% increased risk of mortality (HR 1.96) compared to normal kidney function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: